In the Order of 24 June 2014, establishing "the list of plants, other than mushrooms, authorised in food supplements and the conditions of their use"[16] , ashwagandha does not appear. Why is this? Ashwagandha is on list B of medicinal plants in the French pharmacopoeia, i.e. "Medicinal plants traditionally used as such or in the form of a blend whose potential adverse effects are greater than the expected therapeutic benefit". Its presence on list B is explained by the potentially toxic nature of withanolides in high doses. However, on 14 October 2014, a session of the French Pharmacopoeia Committee on "Medicinal plants and essential oils" reassessed ashwagandha. While "the various studies and publications have not shown any major toxicity of these compounds" and "the negative effects of the plant have always been shown at high doses", the committee decided to keep ashwagandha on the B list.
But is ashwagandha still banned? No, thanks to article 16 of decree no. 2006-352 of 20 March 2006 on food supplements[17]. This article explains that if a substance is legally manufactured and marketed in a European country, it can be marketed in France by following the mutual recognition procedure described in the article. Ashwagandha is authorised elsewhere in Europe, notably in Belgium. It is, therefore, possible to sell ashwagandha-based food supplements in France. In short, ashwagandha was effectively banned from sale in France for some time because of its possible toxicity in high doses, but this is no longer the case, and it is now legal to sell it.





